# Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）

> **NCT02189603** · PHASE4 · COMPLETED · sponsor: **Jun Zhang** · enrollment: 601 (actual)

## Conditions studied

- Hepatitis E

## Interventions

- **BIOLOGICAL:** Recombinant (E. Coli) Hepatitis E Vaccine

## Key facts

- **NCT ID:** NCT02189603
- **Lead sponsor:** Jun Zhang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-12-07
- **Final completion:** 2015-12-07
- **Target enrollment:** 601 (ACTUAL)
- **Last updated:** 2018-08-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02189603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02189603, "Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®）". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02189603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*